Follow
Elaheh Eskandari
Elaheh Eskandari
Medical Informatics and Genetics Center (MedInfoGene) Tehran, Iran
No verified email
Title
Cited by
Cited by
Year
An integrated study on TFs and miRNAs in colorectal cancer metastasis and evaluation of three co-regulated candidate genes as prognostic markers
E Eskandari, F Mahjoubi, J Motalebzadeh
Gene 679, 150-159, 2018
212018
Transcriptomics-based screening of molecular signatures associated with patients overall survival and their key regulators in subtypes of breast cancer
E Eskandari, J Motalebzadeh
Cancer genetics 239, 62-74, 2019
92019
Transcription factors linked to the molecular signatures in the development of hepatocellular carcinoma on a cirrhotic background
J Motalebzadeh, E Eskandari
Medical Oncology 38 (10), 121, 2021
42021
Association of elevated peripheral blood micronucleus frequency and Bmi-1 mRNA expression with metastasis in Iranian breast cancer patients
M Salimi, E Eskandari
Asian Pacific Journal of Cancer Prevention: APJCP 19 (10), 2723, 2018
42018
Comprehensive analysis of DRAIC and TP53TG1 in breast cancer luminal subtypes through the construction of lncRNAs regulatory model
J Motalebzadeh, E Eskandari
Breast Cancer 29 (6), 1050-1066, 2022
32022
Syntrophin beta 1 (SNTB1): candidate as a new marker for colorectal cancer metastasis
J Motalebzadeh, E Eskandari
Gene Reports 20, 100719, 2020
32020
Up-regulation of Bax-interacting factor-1 in Iranian colorectal cancer patients
E Eskandari, M Salimi, F Mahjoubi
Basic & Clinical Cancer Research 10 (2), 25-32, 2018
22018
FBXO39, ETS-1 and H3F3B genes as three candidates for prognosis of colorectal cancer metastasis
J Motalebzadeh, F Mahjoubi, E Eskandari, S Rezayati, N Shakournia, ...
European Journal of Cancer 72, S137, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–8